Unlocking the full potential of oral vaccines

Learn More

Explore the history and impact of the rapidly growing $30 billion global vaccines market.

Our platform supports the rapid development, manufacture and distribution of vaccines.

Explore our development programs.

News & Press

05/07/21

Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Do..

05/04/21

Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boo..

05/03/21

New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests..